P
Peter G. Gibson
Researcher at University of Newcastle
Publications - 774
Citations - 53254
Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma
Ama Tawiah Essilfie,Jay C. Horvat,Richard Kim,Jemma R. Mayall,James W. Pinkerton,Emma L. Beckett,Malcolm R. Starkey,Jodie L. Simpson,Paul S. Foster,Peter G. Gibson,Philip M. Hansbro +10 more
TL;DR: Macrolides have broad anti-inflammatory effects in AAD that are likely independent of their antimicrobial effects and dependent upon the responses that dominate during AAD.
Journal ArticleDOI
Azoles for allergic bronchopulmonary aspergillosis associated with asthma
TL;DR: Itraconazole modifies the immunologic activation associated with allergic bronchopulmonary aspergillosis and improves clinical outcome, at least over the period of 16 weeks.
Journal ArticleDOI
Soluble RAGE is deficient in neutrophilic asthma and COPD
Maria B. Sukkar,Lisa Wood,Melinda Tooze,Jodie L. Simpson,Vanessa M. McDonald,Peter G. Gibson,Peter A. B. Wark +6 more
TL;DR: Airway and systemic levels of sRAGE and the RAGE ligands HMGB1 (high-mobility group box-1) and serum amyloid A (SAA) are related to neutrophilic inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Journal ArticleDOI
The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors.
Peter G. Gibson,Jerry Dolovich,A. Girgis-Gabardo,M M Morris,M. Anderson,F. E. Hargreave,Judah A. Denburg +6 more
TL;DR: Reduced production of eosinophils and basophils after the resolution of an exacerbation of asthma may be due to reduced levels of airway‐derived eo/B and granulocyte‐macrophage growth and differentiation factors.
Journal ArticleDOI
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
Vanessa M. McDonald,Sarah A. Hiles,Krystelle Godbout,Erin S. Harvey,Erin S. Harvey,Guy B. Marks,Guy B. Marks,Mark Hew,Matthew J. Peters,Philip G. Bardin,Paul N. Reynolds,John W. Upham,John W. Upham,Melissa Baraket,Zaheerodin Bhikoo,Jeffrey Bowden,Ben Brockway,Li Ping Chung,Belinda Cochrane,Belinda Cochrane,Gloria Foxley,J. Garrett,Lata Jayaram,Christine Jenkins,Constance H. Katelaris,Constance H. Katelaris,Gregory Katsoulotos,Mariko Siyue Koh,Mariko Siyue Koh,Vicky Kritikos,Vicky Kritikos,Marina Lambert,David Langton,David Langton,Alexis Lara Rivero,Peter G. Middleton,Peter G. Middleton,Aldoph Nanguzgambo,Naghmeh Radhakrishna,Helen K. Reddel,Janet Rimmer,A.M. Southcott,Michael Sutherland,Francis Thien,Peter A. B. Wark,Peter A. B. Wark,Ian A. Yang,E. Yap,Peter G. Gibson,Peter G. Gibson +49 more
TL;DR: This study examined whether treatable traits could be identified using registry data and whether particular treatable trait were associated with future exacerbation risk.